Emergency Department Visits for Adverse Drug Events
Research of Adverse Drug ED Visits. A new study has found that one in 250 individuals will experience an adverse drug reaction and require treatment in an emergency department (ED). Adverse drug event prevention was a target for the Patient Protection and Affordable Care Act of 2010. The result was new programs to further the … [Read more...]
DPP-4 Inhibitor Type 2 Diabetes Drugs Associated with Serious Side Effects
DPP-4 Inhibitor Serious Side Effects. Dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors), a class of oral diabetes medications that includes Januvia, Onglyza, Trajenta, and Nesina, treat Type 2 diabetes by blocking DPP-4. Oral DPP-4 inhibitors work by increasing incretin levels in the pancreas which, in turn, inhibits the release … [Read more...]
FDA Infants taking Proglycem Warning
The Risk Of Proglycem to Children. Proglycem, a drug used to treat low blood sugar, has been associated with reports of pulmonary hypertension in infants and newborns taking the medication, the U.S. Food and Drug Administration (FDA) warned. Pulmonary hypertension is a serious lung condition where there is high blood pressure in … [Read more...]
Statin Risk of Type 2 Diabetes
STATIN MEDICATIONS INCREASE RISK OF TYPE 2 DIABETES. A new study published in Diabetologia shows that use of statin medications, which is often used to lower cholesterol, can significantly increase the risk of developing type 2 diabetes. Medical News Today reports that the association between statin therapy and type 2 diabetes is … [Read more...]
Link Between Januvia and Pancreatic Cancer
Potential Link Between Januvia and Pancreatic Cancer. Federal health officials are set to launch an investigation into a possible link between the type 2 diabetes drug Januvia (sitagliptin) and a risk of pancreatic cancer. According to a New York Times report, the U.S. Food and Drug Administration (FDA) is acting on the research … [Read more...]
Sulfonylureas Risk Of Heart Problems
Sulfonylureas Higher Risk Of Heart Problems. Sulfonylureas, a claid ass of drugs long used in the treatment of type 2 diabetes, have been linked with an increased risk of death and cardiac failure over newer treatments, according to research, writes the Palm Beach Post. The study—which agreed with current American Diabetes … [Read more...]
Lantus Studies Cancer Worries
Lantus Studies Raise Cancer. Lantus, the blockbuster diabetes drug made by Sanofi-Aventis, may increase the risk of cancer in some patients. The possible link, seen in some new European Lantus studies, prompted the European Association for the Study of Diabetes to call for more studies on the drug. Lantus is an insulin analogue - … [Read more...]
